Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil flag Brazil · Delayed Price · Currency is BRL
11.04
+0.04 (0.36%)
Nov 17, 2026, 5:39 PM GMT-3

BVMF:PNVL3 Income Statement

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,0985,5124,9424,4613,9903,225
Revenue Growth
15.20%11.53%10.79%11.79%23.72%14.41%
Cost of Revenue
4,0973,6843,3373,0792,7452,231
Gross Profit
2,0011,8281,6051,3821,245994.64
Selling, General & Admin
1,6991,5481,3951,2101,099907.41
Other Operating Expenses
6.0823.1812.919.538-15.56
Operating Expenses
1,7051,5711,4081,2201,107891.85
Operating Income
295.95256.83197.33161.89137.84102.78
Interest Expense
-167.5-133.94-104.88-102.57-70.03-37.12
Interest & Investment Income
14.5541.2730.9934.3918.1816.63
Other Non Operating Income (Expenses)
28.11-16.49-8.83-6.81-7.012.2
EBT Excluding Unusual Items
171.12147.68114.6286.978.9984.49
Gain (Loss) on Sale of Assets
-1.7-3.53-4.03-2.26-2.07-2.74
Other Unusual Items
0.21.41.976.951.511.49
Pretax Income
169.61145.54112.5691.5878.4383.24
Income Tax Expense
21.1220.947.06-1.32-7.923.81
Net Income
148.5124.61105.5192.9186.3579.43
Net Income to Common
148.5124.61105.5192.9186.3579.43
Net Income Growth
31.61%18.10%13.57%7.60%8.71%41.45%
Shares Outstanding (Basic)
151149149149149150
Shares Outstanding (Diluted)
151150150150149150
Shares Change
0.85%-0.08%0.42%0.38%-0.30%-1.27%
EPS (Basic)
0.990.840.710.620.580.53
EPS (Diluted)
0.990.830.700.620.580.53
EPS Growth
30.81%18.57%12.90%6.90%9.24%43.27%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
307.16350.95101.73182.256.1821.13
Free Cash Flow Per Share
2.042.340.681.220.380.14
Dividend Per Share
---0.252-0.175
Dividend Growth
-----28.37%
Gross Margin
32.82%33.17%32.48%30.97%31.20%30.84%
Operating Margin
4.85%4.66%3.99%3.63%3.45%3.19%
Profit Margin
2.44%2.26%2.14%2.08%2.16%2.46%
Free Cash Flow Margin
5.04%6.37%2.06%4.08%1.41%0.66%
EBITDA
417.64322.52407.54362.04322.41260.56
EBITDA Margin
6.85%5.85%8.25%8.12%8.08%8.08%
D&A For EBITDA
121.6965.69210.2200.15184.57157.77
EBIT
295.95256.83197.33161.89137.84102.78
EBIT Margin
4.85%4.66%3.99%3.63%3.45%3.19%
Effective Tax Rate
12.45%14.38%6.27%--4.58%
Revenue as Reported
6,0985,5124,9424,4613,9903,225
Advertising Expenses
-40.4233.1629.3426.2119.88